BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35381380)

  • 1. Psychiatric Comorbidities in Pediatric Monogenic Diabetes due to GCK Mutation: Impact on Diabetes-Related Quality of Life.
    Michalak A; Szadkowska A; Mlynarski W; Myśliwiec M; Deja G; Skała-Zamorowska E; Jarosz-Chobot P; Borowiec M; Zalepa A; Musiał-Paździor M; Gierak A; Kaźmierczak-Mytkowska A; Wolańczyk T; Fendler W; Butwicka A
    J Acad Consult Liaison Psychiatry; 2022; 63(6):548-556. PubMed ID: 35381380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mild fasting hyperglycemia in children: high rate of glucokinase mutations and some risk of developing type 1 diabetes mellitus.
    Codner E; Rocha A; Deng L; Martínez-Aguayo A; Godoy C; Mericq V; Chung WK
    Pediatr Diabetes; 2009 Sep; 10(6):382-8. PubMed ID: 19309449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studies.
    Steele AM; Wensley KJ; Ellard S; Murphy R; Shepherd M; Colclough K; Hattersley AT; Shields BM
    PLoS One; 2013; 8(6):e65326. PubMed ID: 23799006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying monogenic diabetes in a pediatric cohort with presumed type 1 diabetes.
    Gandica RG; Chung WK; Deng L; Goland R; Gallagher MP
    Pediatr Diabetes; 2015 May; 16(3):227-33. PubMed ID: 25082184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia.
    Steele AM; Shields BM; Wensley KJ; Colclough K; Ellard S; Hattersley AT
    JAMA; 2014 Jan; 311(3):279-86. PubMed ID: 24430320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of monogenic diabetes in the population-based Norwegian Childhood Diabetes Registry.
    Irgens HU; Molnes J; Johansson BB; Ringdal M; Skrivarhaug T; Undlien DE; Søvik O; Joner G; Molven A; Njølstad PR
    Diabetologia; 2013 Jul; 56(7):1512-9. PubMed ID: 23624530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Type 2 diabetes on Glucokinase diabetes (GCK-MODY) phenotype in a Roma (Gypsy) family - case report.
    Stanik J; Kusekova M; Huckova M; Valentinova L; Masindova I; Stanikova D; Ferenczova J; Gasperikova D; Klimes I
    Endocr Regul; 2012 Apr; 46(2):99-105. PubMed ID: 22540858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Changes in the Glucokinase Gene (GCK) Associated with the Diagnosis of Maturity Onset Diabetes of the Young (MODY) in Pregnant Women and Newborns.
    Lepore C; Damaso E; Suazo V; Queiroz R; Junior RL; Moisés E
    Curr Diabetes Rev; 2022; 18(6):e060821195358. PubMed ID: 34365926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk assessment by coronary artery calcium score in subjects with maturity-onset diabetes of the young caused by glucokinase mutations.
    Franco LF; Szarf G; Dotto RP; Dib SA; Moises RS; Giuffrida FMA; Reis AF
    Diabetes Res Clin Pract; 2021 Jun; 176():108867. PubMed ID: 34023340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of the glucokinase impaired function - GCK MODY today.
    Hulín J; Škopková M; Valkovičová T; Mikulajová S; Rosoľanková M; Papcun P; Gašperíková D; Staník J
    Physiol Res; 2020 Dec; 69(6):995-1011. PubMed ID: 33129248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase Mutation.
    Chakera AJ; Steele AM; Gloyn AL; Shepherd MH; Shields B; Ellard S; Hattersley AT
    Diabetes Care; 2015 Jul; 38(7):1383-92. PubMed ID: 26106223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperglycemia caused by mutation of GCK gene in 10 patients analysis of clinical and mutation characteristics].
    Zhang J; Yuan K; Ding SX; Kong YM; Zhu JF; Fang YL; Liang L; Fu JF; Wang CL
    Zhonghua Er Ke Za Zhi; 2019 Jun; 57(6):440-444. PubMed ID: 31216801
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of monogenic diabetes amongst Polish children after a nationwide genetic screening campaign.
    Fendler W; Borowiec M; Baranowska-Jazwiecka A; Szadkowska A; Skala-Zamorowska E; Deja G; Jarosz-Chobot P; Techmanska I; Bautembach-Minkowska J; Mysliwiec M; Zmyslowska A; Pietrzak I; Malecki MT; Mlynarski W
    Diabetologia; 2012 Oct; 55(10):2631-2635. PubMed ID: 22782286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maturity Onset Diabetes of the Young due to Glucokinase, HNF1-A, HNF1-B, and HNF4-A Mutations in a Cohort of Turkish Children Diagnosed as Type 1 Diabetes Mellitus.
    Ozsu E; Cizmecioglu FM; Yesiltepe Mutlu G; Yuksel AB; Calıskan M; Yesilyurt A; Hatun S
    Horm Res Paediatr; 2018; 90(4):257-265. PubMed ID: 30481753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucokinase Deficit Prevalence in Women With Diabetes in Pregnancy: A Matter of Screening Selection.
    Bitterman O; Giuliani C; Festa C; Napoli A
    Front Endocrinol (Lausanne); 2020; 11():268. PubMed ID: 32508747
    [No Abstract]   [Full Text] [Related]  

  • 16. HDL cholesterol as a diagnostic tool for clinical differentiation of GCK-MODY from HNF1A-MODY and type 1 diabetes in children and young adults.
    Fendler W; Borowiec M; Antosik K; Szadkowska A; Deja G; Jarosz-Chobot P; Mysliwiec M; Wyka K; Pietrzak I; Skupien J; Malecki MT; Mlynarski W
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):321-7. PubMed ID: 21521320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic screening of MODY2/GCK mutations in the Norwegian MODY Registry.
    Sagen JV; Bjørkhaug L; Molnes J; Raeder H; Grevle L; Søvik O; Molven A; Njølstad PR
    Pediatr Diabetes; 2008 Oct; 9(5):442-9. PubMed ID: 18399931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Childhood-onset mild diabetes caused by a homozygous novel variant in the glucokinase gene.
    Filibeli BE; Çatli G; Ayranci İ; Manyas H; Kirbiyik Ö; Dündar B
    Hormones (Athens); 2022 Mar; 21(1):163-169. PubMed ID: 34697762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinguishing the lipid profile of GCK-MODY patients and its correlation with hsCRP levels.
    Ping F; Fu J; Xiao X
    Front Endocrinol (Lausanne); 2022; 13():1024431. PubMed ID: 36387841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GCK-MODY in the US National Monogenic Diabetes Registry: frequently misdiagnosed and unnecessarily treated.
    Carmody D; Naylor RN; Bell CD; Berry S; Montgomery JT; Tadie EC; Hwang JL; Greeley SA; Philipson LH
    Acta Diabetol; 2016 Oct; 53(5):703-8. PubMed ID: 27106716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.